PlainRecalls
FDA Drug Low Class III Terminated

Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 mL (NDC 68180-429-03) bottles, Rx only, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA.

Reported: February 13, 2019 Initiated: January 28, 2019 #D-0429-2019

Product Description

Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 mL (NDC 68180-429-03) bottles, Rx only, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA.

Reason for Recall

Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.

Details

Units Affected
9,930 bottles
Distribution
Nationwide within the United States.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 mL (NDC 68180-429-03) bottles, Rx only, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 9,930 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 13, 2019. Severity: Low. Recall number: D-0429-2019.